XML 56 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Note 22 - Fair Value Disclosures (Tables)
12 Months Ended
Dec. 31, 2021
Notes Tables  
Fair Value, by Balance Sheet Grouping [Table Text Block]
  

Fair Value Measured at Reporting Date Using

 
  

Carrying Amount

  

Level 1

  

Level 2

  

Level 3

  

Fair Value

 

At December 31, 2021:

                    

Cash and cash equivalents

 $193,198  $-  $193,198  $-  $193,198 

Note receivable – CEN Biotech Ukraine, LLC – related party

 $44,859  $-  $-  $44,859  $44,859 

Advances to CEN Biotech Ukraine, LLC - related party

 $1,299,328  $-  $-  $1,299,328  $1,299,328 

Loans payable

 $1,688,793  $-  $-  $1,688,793  $1,688,793 

Loans payable – related parties

 $2,701,641  $-  $-  $-  $- 

Convertible notes payable

 $643,330  $-  $-  $1,890,736  $1,890,736 

Convertible notes payable – related parties

 $162,639  $-  $-  $-  $- 

CEBA loan payable

 $31,552  $-  $-  $31,552  $31,552 
  

Carrying Amount

  

Level 1

  

Level 2

  

Level 3

  

Fair Value

 

At December 31, 2020:

                    

Cash and cash equivalents

 $1,908  $-  $1,908  $-  $1,908 

Other receivables

 $113,999  $-  $-  $113,999  $113,999 

Note receivable – CEN Biotech Ukraine, LLC – related party

 $44,859  $-  $-  $44,859  $44,859 

Advances to Emergence Global - related party

 $17,901  $-  $-  $17,901  $17,901 

Advances to CEN Biotech Ukraine, LLC - related party

 $1,179,328  $-  $-  $1,179,328  $1,179,328 

Loans payable

 $527,379  $-  $-  $527,379  $527,379 

Loans payable – related parties

 $1,363,354  $-  $-  $-  $- 

Patent acquisition liability

 $1,380,000  $-  $-  $1,380,000  $1,380,000 

Convertible notes payable

 $6,730,448  $-  $-  $7,766,663  $7,766,663 

Convertible notes payable – related parties

 $2,558,681  $-  $-  $-  $-